Detalhe da pesquisa
1.
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.
Biochem J
; 479(9): 1007-1030, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470373
2.
A novel soluble complement receptor 1 fragment with enhanced therapeutic potential.
J Biol Chem
; 296: 100200, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33334893
3.
Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation.
J Allergy Clin Immunol
; 142(4): 1355-1358, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29936101
4.
A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe.
Nucleic Acids Res
; 38(3): e19, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19942683
5.
YB-1, the E2F pathway, and regulation of tumor cell growth.
J Natl Cancer Inst
; 104(2): 133-46, 2012 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22205655
6.
The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing.
BMC Res Notes
; 4: 148, 2011 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21612654
7.
Potent subunit-specific effects on cell growth and drug sensitivity from optimised siRNA-mediated silencing of ribonucleotide reductase.
J RNAi Gene Silencing
; 5(1): 321-30, 2009 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19771229